Aemetis (AMTX) to Announce Earnings on Thursday

Aemetis (NASDAQ:AMTX) is projected to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Aemetis to post earnings of ($0.29) per share and revenue of $67.6870 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 2:00 PM ET.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The business had revenue of $54.62 million during the quarter, compared to the consensus estimate of $66.70 million. On average, analysts expect Aemetis to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Aemetis Stock Performance

NASDAQ:AMTX opened at $1.62 on Wednesday. Aemetis has a 1 year low of $1.30 and a 1 year high of $3.80. The stock has a market cap of $114.00 million, a price-to-earnings ratio of -1.36 and a beta of 1.48. The business has a fifty day moving average of $1.85 and a 200-day moving average of $2.06.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Ascendiant Capital Markets upped their price objective on shares of Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Wall Street Zen downgraded shares of Aemetis from a “hold” rating to a “sell” rating in a research report on Saturday, June 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $11.88.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AMTX. Vanguard Group Inc. raised its position in Aemetis by 15.3% in the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock worth $5,578,000 after acquiring an additional 329,760 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Aemetis by 5.0% during the 4th quarter. Geode Capital Management LLC now owns 693,453 shares of the specialty chemicals company’s stock valued at $964,000 after purchasing an additional 33,286 shares in the last quarter. Marshall Wace LLP grew its stake in shares of Aemetis by 289.3% in the 4th quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock worth $778,000 after purchasing an additional 415,978 shares during the last quarter. State Street Corp grew its stake in shares of Aemetis by 13.9% in the 4th quarter. State Street Corp now owns 260,299 shares of the specialty chemicals company’s stock worth $362,000 after purchasing an additional 31,700 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in shares of Aemetis in the 2nd quarter worth approximately $634,000. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.